LATAM Airlines pilots in Chile to begin strike at midnight Wednesday
Director Gilbert Fuller sold 1,057 shares of USANA Health Sciences Inc (NASDAQ:USNA) on November 3, 2025, according to a Form 4 filing with the Securities and Exchange Commission. The shares were sold at a price of $21.4799, for a total transaction value of $22,704. Following the transaction, Fuller directly owns zero shares of USANA Health Sciences Inc.This sale comes as USANA’s stock has declined significantly, down nearly 28% over the past six months. Despite this drop, InvestingPro analysis suggests the stock is currently undervalued. Interestingly, while this director is selling, management has been aggressively buying back shares, and the company maintains impressive gross profit margins of 79% with more cash than debt on its balance sheet.Investors seeking deeper insights can access USANA’s comprehensive Pro Research Report, one of 1,400+ available on InvestingPro, which transforms complex financial data into actionable intelligence.
In other recent news, USANA Health Sciences reported disappointing third-quarter results for 2025, with both earnings and revenue missing forecasts. The company recorded an earnings per share of -$0.15, significantly below the expected $0.56, representing a negative surprise of 126.79%. Additionally, USANA’s revenue reached $214 million, falling short of the anticipated $224.97 million by 4.88%. Meanwhile, Solstice Advanced Materials is set to join the S&P 500 index after S&P Dow Jones Indices announced its inclusion. This change will occur following Honeywell International’s planned spinoff of Solstice Advanced Materials, which is expected to be completed by October 30. Honeywell will continue to hold positions in both the S&P 500 and S&P 100 post-transaction. These developments highlight significant movements within the index and earnings landscape.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.